BACKGROUND: Hepatic angiomyolipoma is a rare mesenchyme-derived neoplasm often misdiagnosed as hepatocellular carcinoma, and the treatment for it remains controversial. AIMS: To develop the optimal preoperative diagnoses means and treatment modalities of hepatic angiomyolipoma. METHODS: Retrospective analysis of the clinical features, treatment, and prognostic data of 17 hepatic AML patients admitted to Chinese People's Liberation Army Generation Hospital between 1996 and 2006. RESULTS: Most hepatic angiomyolipoma were solitary. The overall preoperative diagnostic rate was 18% and the most common misdiagnosis was hepatocellular carcinoma (10/17, 59%). In three patients, observation was performed for 2-3 years before being admitted. The tumors increased 1-9 cm in size in all patients. All of the 17 patients finally received various liver resection procedures, and postoperative mortality and morbidity was 0 and 12% (2/17). After a median follow-up period of 73 months, the tumor recurred only in one patient 9 years post-operatively. CONCLUSIONS: Hepatic angiomyolipoma should be suspected in liver tumor patients with normal α-fetoprotein levels and no concomitant hepatitis. Preoperative MRI combined with percutaneous fine-needle biopsy should be the diagnostic methods of choice. Small hepatic AML proved through pathologic examination (<5 cm) may be managed by observation with close follow-up, but surgery is indicated in patients suffering from large tumors or significantly larger tumors during follow-up.
BACKGROUND:Hepatic angiomyolipoma is a rare mesenchyme-derived neoplasm often misdiagnosed as hepatocellular carcinoma, and the treatment for it remains controversial. AIMS: To develop the optimal preoperative diagnoses means and treatment modalities of hepatic angiomyolipoma. METHODS: Retrospective analysis of the clinical features, treatment, and prognostic data of 17 hepatic AMLpatients admitted to Chinese People's Liberation Army Generation Hospital between 1996 and 2006. RESULTS: Most hepatic angiomyolipoma were solitary. The overall preoperative diagnostic rate was 18% and the most common misdiagnosis was hepatocellular carcinoma (10/17, 59%). In three patients, observation was performed for 2-3 years before being admitted. The tumors increased 1-9 cm in size in all patients. All of the 17 patients finally received various liver resection procedures, and postoperative mortality and morbidity was 0 and 12% (2/17). After a median follow-up period of 73 months, the tumor recurred only in one patient 9 years post-operatively. CONCLUSIONS:Hepatic angiomyolipoma should be suspected in liver tumorpatients with normal α-fetoprotein levels and no concomitant hepatitis. Preoperative MRI combined with percutaneous fine-needle biopsy should be the diagnostic methods of choice. Small hepatic AML proved through pathologic examination (<5 cm) may be managed by observation with close follow-up, but surgery is indicated in patients suffering from large tumors or significantly larger tumors during follow-up.
Authors: V Croquet; C Pilette; C Aubé; B Bouju; F Oberti; C Cervi; J P Arnaud; M C Rousselet; J Boyer; P Calès Journal: Eur J Gastroenterol Hepatol Date: 2000-05 Impact factor: 2.566
Authors: Craig A McKinney; James D Geiger; Valerie P Castle; Robert E Ruiz; Peter J Strouse Journal: Pediatr Hematol Oncol Date: 2005 Jan-Feb Impact factor: 1.969
Authors: Ilaria Lenci; Mario Angelico; Giuseppe Tisone; Antonio Orlacchio; Giampiero Palmieri; Mariangela Pinci; Roberta Bombardieri; Paolo Curatolo Journal: J Hepatol Date: 2008-03-31 Impact factor: 25.083
Authors: S Occhionorelli; L Dellachiesa; R Stano; L Cappellari; D Tartarini; S Severi; G M Palini; G C Pansini; G Vasquez Journal: G Chir Date: 2013 Nov-Dec
Authors: Paul Calame; Gaëlle Tyrode; Delphine Weil Verhoeven; Sophie Félix; Anne Julia Klompenhouwer; Vincent Di Martino; Eric Delabrousse; Thierry Thévenot Journal: World J Gastroenterol Date: 2021-05-21 Impact factor: 5.742